During the past decade, Premier Oncology Hematology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Premier Oncology Hematology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Premier Oncology Hematology Associates" are "Breast Cancer" (3 trials), "Breast Adenocarcinoma" (2 trials), "Chronic Myelomonocytic Leukemia" (2 trials), "Clear Cell Renal Cell Carcinoma" (2 trials) and "Myelodysplastic Syndrome" (2 trials). Many other conditions were trialed in "Premier Oncology Hematology Associates" in a lesser frequency.

Most popular intervention types in "Premier Oncology Hematology Associates" are "Drug" (18 trials), "Other" (14 trials), "Biological" (8 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Bevacizumab" (5 trials), "Quality-of-Life Assessment" (4 trials), "Cyclophosphamide" (3 trials) and "Lenalidomide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Premier Oncology Hematology Associates" are 14 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Premier Oncology Hematology Associates". undefined are not yet recruiting, 1 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Premier Oncology Hematology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Premier Oncology Hematology Associates, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".